Open access
Aug 2026
Cardiometabolic drugs after stroke: time to embrace SGLT2 inhibitors and incretin-based therapies?
Stroke is a multifactorial cardiovascular disease (CVD), which predominantly affects older adults. Consequently, cardiovascular risk factors and related comorbidities are highly prevalent among people presenting with acute stroke. These conditions, and the stroke event itself, may require specific pharmacological thera...
H. Ihle-Hansen, H. Ihle-Hansen, R. Blauenfeldt et al.
· Frontiers in stroke · 0 citations